Background: miR9 is an important tumor suppressor microRNA regulated by DNA methylation in various types of cancers.
Methods: We analyzed the methylation status of the 3 members of the miR9 family in 58 cases of Hodgkin lymphoma (HL) in comparison to 15 reactive lymph nodes. We also assessed the relationships between miR9 methylation and Epstein-Barr virus (EBV) infection and several clinicopathological parameters.
Results: We found that 84.5% of HL cases had a methylation in at least 1 of the 3 loci of miR9, whereas none of the nontumoral samples was methylated. The highest rate of methylation was found in miR9-2 (5q14.3) in 74.1% of the HL cases, followed by miR9-3 (15q26.1) in 56.9% and miR9-1 (1q22) in only 8.6% (p < 0.001). The promoter methylation of miR9-3 was more frequent in patients older than 15 years than in children (p = 0.02) and among women rather than men (p = 0.02). However, no significant correlation was found between miR9 methylation and EBV infection.
Conclusion: These results indicate that miR9 methylation, especially miR9-2, is a frequent event in HL and may be involved in HL pathogenesis, irrespective of EBV infection.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1159/000432402 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Epigenetics and Control of Tumor Angiogenesis in Melanoma: An Update with Therapeutic Implications.
Cancers (Basel)
August 2024
Section of Human Anatomy and Histology, Department of Translational Biomedicine and Neuroscience, University of Bari Medical School, 70124 Bari, Italy.
Angiogenesis, the formation of new blood vessels from pre-existing ones, is a crucial process in the progression and metastasis of melanoma. Recent research has highlighted the significant role of epigenetic modifications in regulating angiogenesis. This review comprehensively examines the current understanding of how epigenetic mechanisms, including DNA methylation, histone modifications, and non-coding RNAs, influence angiogenic pathways in melanoma.
View Article and Find Full Text PDFEpigenetic Mechanisms of Aluminum-Induced Neurotoxicity and Alzheimer's Disease: A Focus on Non-Coding RNAs.
Neurochem Res
November 2024
Laboratory of Ecobiomonitoring and Quality Control, Yaroslavl State University, Sovetskaya Str. 14, Yaroslavl, 150000, Russia.
Article Synopsis
- Aluminum (Al) exposure is linked to neurotoxic effects that may contribute to the development of Alzheimer's disease (AD) through epigenetic modifications.
- Studies show that Al disrupts DNA methylation, alters histone modifications, and affects non-coding RNA expression in the brain, impacting key genes involved in neuroprotection and inflammation.
- Changes in DNA and histone modifications due to Al exposure are correlated with cognitive decline in affected individuals, but more research is needed to fully understand these epigenetic mechanisms.
ALOX5AP is a new prognostic indicator in acute myeloid leukemia.
Discov Oncol
November 2023
Laboratory Center, Affiliated People's Hospital of Jiangsu University, Zhenjiang, Jiangsu, China.
Background: The overexpression of ALOX5AP has been observed in many types of cancer and has been identified as an oncogene. However, its role in acute myeloid leukemia (AML) has not been extensively studied. This study aimed to identify the expression and methylation patterns of ALOX5AP in bone marrow (BM) samples of AML patients, and further explore its clinical significance.
View Article and Find Full Text PDFA cuproptosis-related lncRNA signature predicts the prognosis and immune cell status in head and neck squamous cell carcinoma.
Front Oncol
July 2023
Department of Otolaryngology Head & Neck Surgery, Longgang Otolaryngology Hospital, Shenzhen, Guangdong, China.
Introduction: The incidence of head and neck squamous cell carcinoma (HNSCC), one of the most prevalent tumors, is increasing rapidly worldwide. Cuproptosis, as a new copper-dependent cell death form, was proposed recently. However, the prognosis value and immune effects of cuproptosis-related lncRNAs (CRLs) have not yet been elucidated in HNSCC.
View Article and Find Full Text PDFThe emerging role of long non-coding RNAs, microRNAs, and an accelerated epigenetic age in Huntington's disease.
Front Aging Neurosci
September 2022
Malopolska Centre of Biotechnology, Jagiellonian University, Krakow, Poland.
Huntington's disease (HD) is a dominantly inherited neurodegenerative disease with variable clinical manifestations. Recent studies highlighted the contribution of epigenetic alterations to HD progress and onset. The potential crosstalk between different epigenetic layers and players such as aberrant expression of non-coding RNAs and methylation alterations has been found to affect the pathogenesis of HD or mediate the effects of trinucleotide expansion in its pathophysiology.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!